We are part of the Sartorius Stedim Biotech Group, a global provider of laboratory and pharmaceutical equipment.

Based near Cambridge UK, we specialise in the design and manufacture of automated cell culture and fermentation systems for the bio-pharma, regenerative medicine and industrial biotechnology sectors, focusing on:


  • Bioprocess development
  • GMP manufacture of biologics
  • Cell therapy & stem cell research
  • Discovery research

 

 

News

Sartorius Stedim Biotech Introduces Mini Microcarrier Bioreactor for Culturing Adherent Cells More >>


Sartorius Stedim Biotech launches new ambr® 250 high throughput bioreactor system for perfusion culture More >>


Engineer Wins Second Cambridge Regional College Award More >>


Ingenza invests in ambr 250 modular technology for fast fermentation development More >>


Local Firms Invited to Join Exciting STEM Initiative - Helping Children Understand the Appliance of Science More >>


Sartorius Stedim Biotech launches ambr® 15 bioreactor system with Nova BioProfile® FLEX2 integration More >>


Sartorius Stedim Biotech Partners with Nova Biomedical - Firms combine ambr® technology with the BioProfile® FLEX2 More >>


Award-Winning Engineering Apprenticeship Scheme at Royston site now open for applications More >>


New Webinar on Implementing the ambr® 250 Modular Benchtop Bioreactor - With A Case Study From Cobra Biologics More >>


New Webinar on Developing Process Workflows for Rapid Scale-Up - With a Case Study from WuXi Biologics More >>


Sartorius Stedim Biotech launches innovative ambr® 250 modular bioreactor system More >>


WuXi Biologics and Sartorius Stedim Biotech Open Joint R&D Biologics Laboratory in Shanghai More >>


New Poster on High Density Fed-Batch Microbial Screening Using Micro Bioreactors More >>


Sartorius Royston actively recruiting for a variety of roles within this growing business More >>


Science and Technology Workshops Launched for Primary & Middle Schools More >>


Sartorius Royston wins STEM Apprenticeship Employer of the Year and Overall Employer of the Year Awards More >>


Ginkgo Bioworks chooses ambr 250 Systems to enable High Throughput Process Development of Engineered Microbes More >>


New paper from WuXi AppTec on Shortening Timelines for Bioprocessing of Protein-based Therapeutics More >>


New Webinar - ambr15 microbioreactor as a sedimentation-perfusion model More >>


New SelecT Mk5 Automated Cell Culture System Launched on Booth 1223 at SLAS More >>


New ambr 15 fermentation system for enhanced microbial strain screening More >>


RAFT 3D cell culture system to be exclusively distributed by Lonza Bioscience More >>


ReNeuron to use Cellmate Automated Cell Culture for Stem Cell-based Stroke Therapy More >>


New webinar: Using ambr 250 for effective scale-up to cGMP manufacture of biotherapeutics More >>


ambr 15 and ambr 250 bioreactor systems enhanced with Design of Experiments (DoE) software More >>


 

Scalable T-Cell Expansion in Stirred Tank Bioreactors
Focus on: On-Demand Webinar “Online Biomass Monitoring for ambr® 15 fermentation”

During this on-demand webinar Alison Rees-Manley, ambr 15 Product Manager, discusses the ambr 15 fermentation system and the newly integrated online biomass measurement technology.

Comparison of online data with conventional OD600 absorbance measurements for E. coli, S. cerevisiae and P. pastoris have shown broad applicability with different organisms over a wide range of conditions, as well as highlighting the added value that real-time bioprocess data provides.

Request access to this on-demand webinar.

 

 

View our latest job opportunities